Pharmacy Report Archives - Page 19 of 139 - Becker's Hospital Review

Big lessons for 12 pharmacy execs | Optum Rx alters pharmacy reimbursements | 10 systems seeking pharmacy leaders | A case for 340B spend audits | VCU fast-tracks PharmD path

March 20, 2025 BHR Newsletter 1. VCU launches accelerated PharmD program Full story 2. The case for auditing 340B spend Full story 3. Optum Rx's new payment model favors brand names over generics Full story 4. AI in the ED —…

Patient death linked to gene therapy | Ohio hospital pharmacy to close | ScionHealth + Mark Cuban: 3 details | Optum Rx drops some prior auths | Purdue to pay $7.4B for opioid crisis

March 19, 2025 BHR Newsletter 1. 1st patient death linked to muscular dystrophy treatment Full story 2. Struggling Ohio hospital's pharmacy to close Full story 3. Optum Rx to drop prior authorization for dozens of prescription drugs Full story 4.…

Merck to close Pa. plant | Wegovy, Zepbound not cost-effective: Study | HHS chimes in on 340B rebate case | CHS' top-earning execs | La. system rebrands

March 18, 2025 BHR Newsletter 1. Merck to lay off 163, shutter Pennsylvania plant Full story 2. HHS files brief in 340B rebate model case: 4 takeaways Full story 3. Zepbound, Wegovy fail to justify prices: Study Full story 4.…

CMS doubles down on drug price negotiations | How MetroHealth combats pharma deserts | New stroke drug beats decades-old treatment | Trump signs funding bill: What to know | 10 most, least overweight cities

March 17, 2025 BHR Newsletter 1. CMS doubles down on Medicare drug price negotiations Full story 2. How MetroHealth is expanding access in a pharmacy desert Full story 3. New stroke drug compares favorably to decades-old treatment: Study Full story 4. 45…

CMS cancels $2 drug plan | 10 drugs poised to be top-sellers | Trump drops CDC nominee | 10 systems seeking pharmacy leaders | Gene therapies 'tip of the iceberg': Children's National exec

March 13, 2025 BHR Newsletter 1. GOP House leaders block vote to end Trump tariffs: 4 things to know Full story 2. 10 drugs poised to be best-sellers in 2026 Full story 3. CMS cancels $2 generic drug plan Full story…

Civica Rx's 2025 plans | Hospitals shrug GPOs for drugmakers | Why Ozempic might slow aging | 6 most lucrative drug markets | Ohio hospital limits admissions

March 12, 2025 BHR Newsletter 1. Innovation despite 'white knuckle time' in healthcare Full story 2. Inside Civica Rx's 2025 sourcing, expansion strategies Full story 3. HIV drug could offer yearlong protection with a single shot Full story 4. More…

Care New England taps pharmacy VP | Pharmacist to forfeit $405M tied to fraud scheme | The $8.8B gender gap in Rx costs: 4 notes | GLP-1s reshape service lines | Nashville hospital curbs CEO's power

March 11, 2025 BHR Newsletter 1. Drug doubles brain cancer survival time in trial Full story 2. Care New England names pharmacy VP Full story 3. Women spent $8.8B more than men on medications in 2024: 4 takeaways Full story…

CVS to open smaller pharmacies: 5 details | 100 drugs at risk of shortage: USP | A common drug's potential for cancer care | 10 top threats to patient safety | UVA board member resigns after CEO's exit

March 10, 2025 BHR Newsletter 1. USP's list of vulnerable medications: What to know Full story 2. CVS to open smaller, pharmacy-focused stores: 5 things to know Full story 3. ASHP partners with ShiftRx on pharmacy workforce staffing Full story…

Top ambulatory pharmacy practices: ISMP | For $10B, Walgreens to go private | 10 wins for WVU Medicine pharmacy | FDA scolds drugmaker over false claims | Healthcare job losses by state if ACA credits end

March 7, 2025 BHR Newsletter 1. Best practices for ambulatory pharmacies: ISMP Full story 2. Walgreens to go private in $10B deal Full story 3. FDA scolds drugmaker for 'false or misleading' claims Full story 4. Every minute spent on…

ASHP to DEA: Allow pharmacists to prescribe MOUDs | 10 systems seeking pharmacy leaders | HCA's top-paid execs | CAR T-cell therapies, explained | 3 GLP-1 updates

March 6, 2025 BHR Newsletter 1. CAR T, explained Full story 2. Allow pharmacists to prescribe some controlled substances: ASHP to DEA Full story 3. 3 GLP-1 updates Full story 4. Health IT leaders are rethinking infrastructure. The trends shaping…